- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06713759
Impact of Postural Balance Changes on Low Back Pain During Pregnancy (LBP)
November 28, 2024 updated by: Nada Fawzy Ali, October 6 University
this study will be conducted to determine the impact of postural balance changes on low back pain during pregnancy
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
Back pain is a major problem in the general population, and it is thought to be even more common in pregnant women who have given birth.
It has been hypothesized that this type of pregnancy-related low back pain (LBP) may be related to changes in lumbar posture, perhaps accompanied by stretching abdominal muscles or specific hormonal effects of pregnancy .During pregnancy, many hormonal, anatomical, and musculoskeletal changes occur.
These changes alter the postural balance and increase the risk of falls.
Falls during pregnancy can cause maternal and foetal injuries.
Moreover, the incidence of falls during pregnancy is higher compared to non-pregnant women of the same age.
The risk of falls increases with the gestational age, and most falls are experienced in the third trimester.
so, this study will be designed to conduct new information about the relation between postural changes and low back pain during pregnancy
Study Type
Observational
Enrollment (Estimated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: nada Ali, master
- Phone Number: 01140767665
- Email: nodadoda24@gmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
This study will be conducted on forty pregnant women (in second and third trimesters) suffering from low back pain
Description
Inclusion Criteria:
- Pregnant women in 2nd and 3rd trimesters.
- Pregnant women suffering from low back pain
- Their Age will range from 20-35 years.
- Their Body mass index (BMI) will be less than 35 kg/m2
Exclusion Criteria:
- Non pregnant women.
- Women who have any history of diseases associated with balance disorder
- Women who have any Neurological disorders.
- Women who have Lower limbs deformities
- Women who have Optical problems and disorders
- Women who have Cerebrovascular disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
primigravida women
This group will include 20 primigravida pregnant woman with low back pain.
They will undergo balance and low back pain assessment (at 2 different time points: one at their second trimester (22-24) weeks and the other one in their third trimester (34th) week
|
|
Multigravida women
This group will include 20 pregnant women with low back pain.
They will undergo balance and low back pain assessment (at 2 different time points: one at their second trimester (22-24) weeks and the other one in their third trimester (34th) week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
balance
Time Frame: up to thirty four weeks
|
The Biodex Balance System SD will be used to assess balance.higher
values indicate more deviations and poor balance control.
|
up to thirty four weeks
|
|
pressure pain threshold
Time Frame: up to thirty four weeks
|
digital pressure algometer from Wagner Instruments will be used to assess pressure pain threshol.The algometer was set to measure at a rate of 100 readings per second and always displayed the highest pressure measured.
The round attachment surface had a diameter of 1.12 cm.
Newton (N) was set as the unit of measurement on the device.
Later, it was converted to kilopascals (kPa) to enable comparability with other studies
|
up to thirty four weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pain intensity
Time Frame: up to thirty four weeks
|
visual analogue scale will be used to assess pain intensity.
Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100.
A higher score indicates greater pain intensity.
|
up to thirty four weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 5, 2024
Primary Completion (Estimated)
February 5, 2025
Study Completion (Estimated)
February 5, 2025
Study Registration Dates
First Submitted
November 28, 2024
First Submitted That Met QC Criteria
November 28, 2024
First Posted (Actual)
December 3, 2024
Study Record Updates
Last Update Posted (Actual)
December 3, 2024
Last Update Submitted That Met QC Criteria
November 28, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/005384
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.